FDA advisers back gene therapy for rare form of blindness – Nature.com
Nature.com |
FDA advisers back gene therapy for rare form of blindness
Nature.com Advisers to the US Food and Drug Administration (FDA) have paved the way for the agency’s first approval of a gene therapy to treat a disease caused by a genetic mutation. On 12 October, a panel of external experts unanimously voted that the benefits … FDA advisers urge approval for first gene therapy for inherited diseaseWashington Post FDA Panel Advises Approval of Gene Therapy for Blinding DiseaseNBCNews.com FDA Vote Sets Stage for Gene Therapy’s FutureMIT Technology Review Science Magazine –New England Journal of Medicine –The Lancet –OHSU all 172 news articles » |
Business Insider |
A first-of-its-kind treatment for blindness just got one step closer to approval
Business Insider Gene therapy hereditary blindness eye exam In this Oct. 4, 2017 photo, Dr. Albert Maguire checks the eyes of Misa Kaabali, 8, at the Children’s Hospital of Philadelphia. Misa was 4 years old when he received his gene therapy treatment. AP. A US Food … |
Business Insider |
A first-of-its-kind treatment for blindness just got one step closer to approval
Business Insider Gene therapy hereditary blindness eye exam In this Oct. 4, 2017 photo, Dr. Albert Maguire checks the eyes of Misa Kaabali, 8, at the Children’s Hospital of Philadelphia. Misa was 4 years old when he received his gene therapy treatment. AP. A US Food … |
NPR |
FDA Panel Endorses Gene Therapy For A Form Of Childhood Blindness
NPR A Food and Drug Administration advisory committee endorsed the first gene therapy for an inherited disorder — a rare condition that causes a progressive form of blindness that usually starts in childhood. The recommendation came in a unanimous 16-0 … Gene Therapy: How a New Cure for Blindness Reverses Retinal DystrophyNewsweek The Time Has Come: 4 Gene Therapy Stocks to Buy, 1 to AvoidBarron’s FDA Vote Sets Stage for Gene Therapy’s FutureMIT Technology Review Bloomberg –ABC News –Futurism all 81 news articles » |
The San Diego Union-Tribune |
HIV controlled with improved CAR T therapy; human testing planned next spring
The San Diego Union-Tribune A breakthrough cancer treatment is to be tested in patients next year for its original purpose, controlling HIV infection. Researchers at the University of Pennsylvania, where its use in cancer was pioneered, say they’ve tweaked multiple facets of what … Reengineered immune system cells show early promise against HIVMedical Xpress Our best chance to end cancerThe Daily Reckoning |
|
Israeli researcher: immunotherapy ‘future’ of treatment
Cleveland Jewish News Yarden: Immunotherapy is at the very heart of my research. One clear way to void the growth factors is to use antibodies. Antibodies are molecules – we can engineer them to get rid of growth factors. Now, we can engineer the antibodies to make them … |